MA
TEVA icon

MUFG Americas’s Teva Pharmaceuticals TEVA Stock Holding History

MUFG Americas’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-22,950
Closed -$762K – 1219
2017
Q2 		$762K Buy
22,950
+22,700
+9,080% +$703K 0.02% 313
2017
Q1 		$8K Sell
250
-3,450
-93% -$118K ﹤0.01% 881
2016
Q4 		$134K Sell
3,700
-4,841
-57% -$193K ﹤0.01% 477
2016
Q3 		$393K Buy
8,541
+27
+0.3% +$1.41K 0.01% 385
2016
Q2 		$428K Sell
8,514
-4,356
-34% -$232K 0.01% 350
2016
Q1 		$688K Buy
12,870
+5,900
+85% +$346K 0.02% 312
2015
Q4 		$457K Sell
6,970
-1,372
-16% -$84.8K 0.02% 355
2015
Q3 		$471K Sell
8,342
-511
-6% -$33.1K 0.02% 367
2015
Q2 		$523K Sell
8,853
-542
-6% -$33.4K 0.02% 367
2015
Q1 		$586K Sell
9,395
-1,387
-13% -$80.6K 0.02% 360
2014
Q4 		$620K Sell
10,782
-150
-1% -$8.36K 0.02% 354
2014
Q3 		$587K Sell
10,932
-500
-4% -$26.5K 0.02% 352
2014
Q2 		$599K Sell
11,432
-2,360
-17% -$121K 0.02% 357
2014
Q1 		$728K Sell
13,792
-7,433
-35% -$344K 0.02% 329
2013
Q4 		$851K Sell
21,225
-55,228
-72% -$2.17M 0.03% 304
2013
Q3 		$2.89M Sell
76,453
-69,967
-48% -$2.73M 0.1% 184
2013
Q2 		$5.74M Buy
+146,420
New +$5.7M 0.11% 195

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MUFG Americas's TEVA Position: Q3 2017 in Review

MUFG Americas sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 22,950 shares — an estimated $762K sold.

MUFG Americas first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $5.74M in Q2 2013. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • MUFG Americas reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • MUFG Americas sold 22,950 Teva Pharmaceuticals shares in Q3 2017, an estimated $762K.
  • MUFG Americas first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • MUFG Americas's Teva Pharmaceuticals position peaked at $5.74M in Q2 2013.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on MUFG Americas's 13F filing for Q3 2017, filed 13 Nov 2017.